未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial 一种新型10%静脉免疫球蛋白(IVIG)在中国原发性免疫性血小板减少症(ITP)患者中的有效性与安全性:一项多中心、单臂、III期临床试验 Cai, Huacong; Wang, Jishi; Yan, Zhenyu; Zhou, Hu; Li, Zhenyu; Yang, Feng'e; Guo, Pengxiang; Gao, Da; Jin, Jie; Zeng, Yun; Wang, Shujie 分享 收藏
分享 收藏
A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study 一种新型JAK2抑制剂OB756在治疗Janus Kinase抑制剂初治的骨髓纤维化患者中的研究:一项1/2期、开放标签、多中心研究 Zhou, Yile; Huang, Jian; Wen, Bingbing; Zhou, Hu; Yang, Wei; Fan, Lianlian; Gong, Tiejun; Gao, Sujun; Jiao, Zongjiu; Liu, Qingchi; Zhao, Lidong; Wu, Guocai; Wu, Cuicui; Wang, Jun; Zhang, Jin; Fu, Jiaping; Sheng, Zengmei; Zhu, Zunmin; Lu, Jian; Zhang, Yi; Jin, Jie 分享 收藏
Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: An Open-Label, Multicenter, Phase 2 Clinical Trial in China Ponatinib 2年疗效、安全性和健康相关生活质量:中国一项开放标签、多中心、II期临床试验,用于费城染色体阳性白血病患者 Yu, Lu; Wang, Huifang; Liu, Xiaoli; Liu, Bingcheng; Zhao, Xielan; He, Qun; Zeng, Qingshu; Sun, Zimin; Liu, Ting; Zhu, Huanling; Liu, Zhuogang; Du, Xin; Jin, Jie; Meng, Li; Hou, Ming; Chen, Suning; Yang, Linhua; Xian, Mingji; Kotobuki, Yoshitaka; Zhang, Shuang; Jiang, Qian 分享 收藏
Impact of Different Therapeutic Regimen on Prognosis in CEBPA bZIP-Inf Acute Myeloid Leukemia 不同治疗方案对CEBPA bZIP-Inf急性髓系白血病预后的影响 Pan, Jiajia; Chen, Nianci; Mao, Liping; Lou, Yinjun; Zhang, Yi; Suo, Shanshan; Zhou, Yile; Li, Chenying; Li, Xia; Yang, Xueying; Ling, Qing; Ye, Wenle; Lin, Xiangjie; Wang, Huafeng; Jin, Jie 分享 收藏
Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus Vrd in Chinese Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant: IMROZ Subgroup Analysis Isatuximab 联合硼替佐米、来那度胺和地塞米松(Isa-VRd)与 VRd 方案对比,适用于不适合移植的中国新诊断多发性骨髓瘤患者的 IMROZ 亚组分析 An, Gang; Liu, Zhuogang; Jin, Jie; Cai, Zhen; Li, Wei; Xia, Zhongjun; Cen, Xinan; Hu, Yu; Mi, Jian-Qing; Jing, Hongmei; Zhan, Rong; Qu, Xiaoyan; Du, Xin; Gao, Dan; Zhao, Liang; Qiu, Lugui 分享 收藏
Preliminary Efficacy and Safety of the CK1e/PI3KS Dual Inhibitor HZ-H08905 in Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphomas: Results from the Phase 1 HZ-H08905-101 Study HZ-H08905-101研究:CK1e/PI3KS双抑制剂HZ-H08905在复发和/或难治性外周T细胞淋巴瘤患者中的初步疗效与安全性结果 Wei, Juying; Yu, Wenjuan; Jin, Zhengming; Zhou, Keshu; Yang, Haiyan; Li, Fei; Li, Lanfang; Zhang, Bo; Hu, Miao; Zhang, Yanping; Zhou, Xinglu; Jin, Jie 分享 收藏
Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study (Sept, 10.1007/s00277-024-05958-8, 2024) Fu, Weijun; Bang, Soo-Mee; Huang, Honghui; Kim, Kihyun; Li, Wei; An, Gang; Lee, Je-Jung; Cai, Zhen; Jin, Jie; Wang, Yafei; Chim, Chor Sang; Carson, Robin; Liu, Rui; Zhao, Man; Chen, Xi; Cui, Canchan; Hou, Jian; Wang, Jianxiang 分享 收藏
Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study Fu, Weijun; Bang, Soo-Mee; Huang, Honghui; Kim, Kihyun; Li, Wei; An, Gang; Lee, Je-Jung; Cai, Zhen; Jin, Jie; Wang, Yafei; Chim, Chor Sang; Carson, Robin; Liu, Rui; Zhao, Man; Chen, Xi; Cui, Canchan; Hou, Jian; Wang, Jianxiang 分享 收藏
分享 收藏
分享 收藏
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial 普通波马利多明联合小剂量地塞米松治疗复发或难治性多发性骨髓瘤的疗效和安全性: 一项多中心、开放标签、单臂试验 Zhou, Huixing; Wang, Yafei; Chen, Jiao; He, Aili; Jin, Jie; Lu, Quanyi; Zhao, Ying; Li, Junjun; Hou, Ming; Su, Liping; Lai, Xun; Wang, Wei; Liu, Lihong; Ma, Yanping; Gao, Da; Lai, Wenhong; Zhou, Xin; Jing, Hongmei; Zhang, Jinqiao; Yang, Wei; Ran, Xuehong; Lin, Congmeng; Hao, Jianping; Xiao, Taiwu; Huang, Zhenqian; Zhu, Zhigang; Wang, Qing; Fang, Baijun; Wang, Binghua; Song, Yanping; Cai, Zhen; Liu, Bo; Zhu, Yanan; Yang, Xinai; Kang, Xiaoyan; Li, Juan; Chen, Wenming 分享 收藏